| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | keratin filament | 8.54e-09 | 97 | 33 | 6 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 1.33e-06 | 227 | 33 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.12e-06 | 263 | 33 | 6 | GO:0045111 | |
| GeneOntologyCellularComponent | mucus layer | 7.24e-06 | 3 | 33 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | perikaryon | 2.46e-05 | 223 | 33 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | axon | 4.03e-04 | 891 | 33 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | Golgi lumen | 6.71e-04 | 109 | 33 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 2.55e-03 | 899 | 33 | 6 | GO:0099513 | |
| MousePheno | abnormal tooth color | 1.33e-10 | 40 | 28 | 6 | MP:0013129 | |
| MousePheno | increased thigmotaxis | 2.01e-07 | 132 | 28 | 6 | MP:0002797 | |
| MousePheno | increased kidney weight | 3.50e-07 | 145 | 28 | 6 | MP:0003917 | |
| MousePheno | abnormal jaw morphology | JAG2 PAPPA2 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 5.48e-07 | 530 | 28 | 9 | MP:0000454 |
| MousePheno | abnormal viscerocranium morphology | JAG2 PAPPA2 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 1.40e-06 | 593 | 28 | 9 | MP:0005274 |
| MousePheno | increased anxiety-related response | 2.00e-06 | 311 | 28 | 7 | MP:0001363 | |
| MousePheno | abnormal kidney weight | 2.89e-06 | 208 | 28 | 6 | MP:0002707 | |
| MousePheno | abnormal mouth morphology | JAG2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 3.84e-06 | 670 | 28 | 9 | MP:0000452 |
| MousePheno | abnormal thymus morphology | JAG2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 6.69e-06 | 717 | 28 | 9 | MP:0000703 |
| MousePheno | abnormal thymus size | PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 1.02e-05 | 564 | 28 | 8 | MP:0002364 |
| MousePheno | abnormal cranium morphology | JAG2 PAPPA2 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 1.84e-05 | 813 | 28 | 9 | MP:0000438 |
| MousePheno | enlarged thymus | 2.02e-05 | 292 | 28 | 6 | MP:0000709 | |
| MousePheno | abnormal craniofacial bone morphology | JAG2 PAPPA2 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 2.11e-05 | 827 | 28 | 9 | MP:0002116 |
| MousePheno | abnormal tooth morphology | 3.26e-05 | 318 | 28 | 6 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 3.32e-05 | 319 | 28 | 6 | MP:0030254 | |
| MousePheno | abnormal facial morphology | JAG2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 4.51e-05 | 910 | 28 | 9 | MP:0003743 |
| MousePheno | abnormal brain interneuron morphology | 5.34e-05 | 37 | 28 | 3 | MP:0004101 | |
| MousePheno | enlarged kidney | 5.94e-05 | 354 | 28 | 6 | MP:0003068 | |
| MousePheno | craniofacial phenotype | JAG2 PAPPA2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 2.01e-04 | 1372 | 28 | 10 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | JAG2 PAPPA2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 2.01e-04 | 1372 | 28 | 10 | MP:0000428 |
| MousePheno | abnormal head morphology | JAG2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 2.25e-04 | 1120 | 28 | 9 | MP:0000432 |
| MousePheno | abnormal endocrine gland morphology | JAG2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 2.64e-04 | 1144 | 28 | 9 | MP:0013560 |
| MousePheno | abnormal sensory neuron morphology | 2.90e-04 | 473 | 28 | 6 | MP:0000965 | |
| MousePheno | d-loop transposition of the great arteries | 2.98e-04 | 13 | 28 | 2 | MP:0011665 | |
| MousePheno | abnormal fear/anxiety-related behavior | KRTAP9-9 PLAUR KRTAP9-6 AOPEP KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 3.22e-04 | 919 | 28 | 8 | MP:0002065 |
| MousePheno | abnormal axial skeleton morphology | JAG2 PAPPA2 PCSK5 KRTAP9-9 MEGF8 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 3.32e-04 | 1458 | 28 | 10 | MP:0002114 |
| MousePheno | loss of cortex neurons | 3.47e-04 | 14 | 28 | 2 | MP:0003241 | |
| MousePheno | abnormal kidney size | 4.06e-04 | 714 | 28 | 7 | MP:0002706 | |
| MousePheno | abnormal anxiety-related response | 5.04e-04 | 740 | 28 | 7 | MP:0001362 | |
| MousePheno | abnormal somatic nervous system morphology | 6.72e-04 | 1025 | 28 | 8 | MP:0002752 | |
| MousePheno | mesocardia | 7.19e-04 | 20 | 28 | 2 | MP:0000650 | |
| MousePheno | decreased locomotor activity | 9.93e-04 | 829 | 28 | 7 | MP:0001402 | |
| MousePheno | complete atrioventricular septal defect | 1.22e-03 | 26 | 28 | 2 | MP:0010413 | |
| MousePheno | abnormal neuronal migration | 1.49e-03 | 114 | 28 | 3 | MP:0006009 | |
| MousePheno | hyperactivity | PCSK5 KRTAP9-9 KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 CNTNAP2 | 1.62e-03 | 1172 | 28 | 8 | MP:0001399 |
| Domain | EGF | CNTNAP3 JAG2 PCSK5 CD93 CNTNAP3B RELN MEGF8 MEGF11 CRB1 CNTNAP2 | 5.90e-12 | 235 | 33 | 10 | SM00181 |
| Domain | EGF-like_dom | CNTNAP3 JAG2 PCSK5 CD93 CNTNAP3B RELN MEGF8 MEGF11 CRB1 CNTNAP2 | 1.05e-11 | 249 | 33 | 10 | IPR000742 |
| Domain | Keratin_B2_2 | 5.89e-11 | 39 | 33 | 6 | PF13885 | |
| Domain | EGF_3 | 2.01e-10 | 235 | 33 | 9 | PS50026 | |
| Domain | EGF_2 | 5.83e-10 | 265 | 33 | 9 | PS01186 | |
| Domain | KAP | 7.13e-10 | 58 | 33 | 6 | IPR002494 | |
| Domain | EGF_1 | 1.12e-08 | 255 | 33 | 8 | PS00022 | |
| Domain | EGF-like_CS | 1.34e-08 | 261 | 33 | 8 | IPR013032 | |
| Domain | LAM_G_DOMAIN | 5.71e-07 | 38 | 33 | 4 | PS50025 | |
| Domain | Galactose-bd-like | 6.16e-07 | 94 | 33 | 5 | IPR008979 | |
| Domain | Laminin_G_2 | 7.06e-07 | 40 | 33 | 4 | PF02210 | |
| Domain | Keratin_B2 | 7.06e-07 | 40 | 33 | 4 | PF01500 | |
| Domain | LamG | 1.04e-06 | 44 | 33 | 4 | SM00282 | |
| Domain | EGF | 2.63e-06 | 126 | 33 | 5 | PF00008 | |
| Domain | Laminin_G | 3.20e-06 | 58 | 33 | 4 | IPR001791 | |
| Domain | VWC_out | 4.78e-06 | 19 | 33 | 3 | SM00215 | |
| Domain | FA58C | 6.54e-06 | 21 | 33 | 3 | SM00231 | |
| Domain | FA58C_3 | 6.54e-06 | 21 | 33 | 3 | PS50022 | |
| Domain | FA58C_1 | 6.54e-06 | 21 | 33 | 3 | PS01285 | |
| Domain | FA58C_2 | 6.54e-06 | 21 | 33 | 3 | PS01286 | |
| Domain | Growth_fac_rcpt_ | 7.49e-06 | 156 | 33 | 5 | IPR009030 | |
| Domain | - | 8.07e-06 | 73 | 33 | 4 | 2.60.120.260 | |
| Domain | F5_F8_type_C | 9.92e-06 | 24 | 33 | 3 | PF00754 | |
| Domain | FA58C | 9.92e-06 | 24 | 33 | 3 | IPR000421 | |
| Domain | hEGF | 1.60e-05 | 28 | 33 | 3 | PF12661 | |
| Domain | - | 2.30e-05 | 95 | 33 | 4 | 2.60.120.200 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.41e-05 | 32 | 33 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.41e-05 | 32 | 33 | 3 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 2.41e-05 | 32 | 33 | 3 | PS00514 | |
| Domain | EGF_Ca-bd_CS | 2.49e-05 | 97 | 33 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.70e-05 | 99 | 33 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.81e-05 | 100 | 33 | 4 | PS00010 | |
| Domain | VWFC_1 | 3.45e-05 | 36 | 33 | 3 | PS01208 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.53e-05 | 106 | 33 | 4 | IPR000152 | |
| Domain | ConA-like_dom | 3.85e-05 | 219 | 33 | 5 | IPR013320 | |
| Domain | VWC | 4.06e-05 | 38 | 33 | 3 | SM00214 | |
| Domain | VWFC_2 | 4.06e-05 | 38 | 33 | 3 | PS50184 | |
| Domain | WxxW_domain | 4.52e-05 | 6 | 33 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.52e-05 | 6 | 33 | 2 | PF13330 | |
| Domain | VWF_dom | 5.50e-05 | 42 | 33 | 3 | IPR001007 | |
| Domain | EGF_CA | 6.12e-05 | 122 | 33 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.52e-05 | 124 | 33 | 4 | IPR001881 | |
| Domain | EGF_extracell | 1.61e-04 | 60 | 33 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.61e-04 | 60 | 33 | 3 | PF07974 | |
| Domain | TIL | 1.98e-04 | 12 | 33 | 2 | PF01826 | |
| Domain | C8 | 1.98e-04 | 12 | 33 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.33e-04 | 13 | 33 | 2 | IPR014853 | |
| Domain | C8 | 2.33e-04 | 13 | 33 | 2 | SM00832 | |
| Domain | TIL_dom | 2.72e-04 | 14 | 33 | 2 | IPR002919 | |
| Domain | VWFD | 3.58e-04 | 16 | 33 | 2 | PS51233 | |
| Domain | VWD | 3.58e-04 | 16 | 33 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.58e-04 | 16 | 33 | 2 | IPR001846 | |
| Domain | VWD | 3.58e-04 | 16 | 33 | 2 | PF00094 | |
| Domain | CTCK_1 | 4.55e-04 | 18 | 33 | 2 | PS01185 | |
| Domain | EGF_CA | 4.65e-04 | 86 | 33 | 3 | PF07645 | |
| Domain | CT | 6.84e-04 | 22 | 33 | 2 | SM00041 | |
| Domain | Cys_knot_C | 8.85e-04 | 25 | 33 | 2 | IPR006207 | |
| Domain | CTCK_2 | 8.85e-04 | 25 | 33 | 2 | PS01225 | |
| Domain | Laminin_EGF | 1.74e-03 | 35 | 33 | 2 | PF00053 | |
| Domain | EGF_Lam | 1.74e-03 | 35 | 33 | 2 | SM00180 | |
| Domain | Laminin_EGF | 2.05e-03 | 38 | 33 | 2 | IPR002049 | |
| Pathway | REACTOME_KERATINIZATION | 5.15e-08 | 217 | 24 | 7 | M27640 | |
| Pathway | REACTOME_KERATINIZATION | 1.70e-07 | 153 | 24 | 6 | MM15343 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.42e-05 | 502 | 24 | 7 | MM14537 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.72e-04 | 21 | 24 | 2 | MM15706 | |
| Pubmed | An ultra-high sulfur keratin gene is expressed specifically during hair growth. | 1.26e-17 | 8 | 33 | 6 | 2465353 | |
| Pubmed | 1.02e-13 | 26 | 33 | 6 | 15454262 | ||
| Pubmed | 1.03e-12 | 37 | 33 | 6 | 11279113 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | KRTAP9-9 MEGF8 KRTAP9-6 MUC2 KRTAP9-1 KRTAP9-2 KRTAP9-8 KRTAP9-3 | 1.55e-11 | 205 | 33 | 8 | 12040188 |
| Pubmed | 5.18e-11 | 69 | 33 | 6 | 18721477 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 22691042 | ||
| Pubmed | 5.24e-07 | 17 | 33 | 3 | 26389685 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17203232 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 31150793 | ||
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 8.73e-07 | 2 | 33 | 2 | 12527922 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 26807827 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17321686 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 8.73e-07 | 2 | 33 | 2 | 20731025 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 11445551 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23832517 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23832516 | ||
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 8.73e-07 | 2 | 33 | 2 | 14594655 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12820724 | ||
| Pubmed | Differences in the expression of mucins in various forms of cystitis glandularis. | 2.62e-06 | 3 | 33 | 2 | 17659847 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18825309 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 15914641 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18300795 | ||
| Pubmed | Gene expression profiling of colorectal mucinous adenocarcinomas. | 2.62e-06 | 3 | 33 | 2 | 20485009 | |
| Pubmed | Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. | 2.62e-06 | 3 | 33 | 2 | 17333267 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23464473 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24920497 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19718741 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 33154304 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 15316081 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 5.23e-06 | 4 | 33 | 2 | 24901817 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25638393 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 36367122 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 17471237 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 5.23e-06 | 4 | 33 | 2 | 22269464 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 5.23e-06 | 4 | 33 | 2 | 29869461 | |
| Pubmed | [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. | 5.23e-06 | 4 | 33 | 2 | 17991319 | |
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 5.23e-06 | 4 | 33 | 2 | 20929551 | |
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 5.23e-06 | 4 | 33 | 2 | 12391274 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23807779 | ||
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 5.23e-06 | 4 | 33 | 2 | 27298226 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23619266 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 5.23e-06 | 4 | 33 | 2 | 17401217 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 12676567 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25298197 | ||
| Pubmed | 8.09e-06 | 41 | 33 | 3 | 22675208 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.72e-06 | 5 | 33 | 2 | 11062147 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12507512 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12093160 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12135769 | ||
| Pubmed | pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. | 8.72e-06 | 5 | 33 | 2 | 10611155 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 22261707 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 8.72e-06 | 5 | 33 | 2 | 16188033 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 8.72e-06 | 5 | 33 | 2 | 16475027 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 19110483 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 16142311 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 17982272 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.31e-05 | 6 | 33 | 2 | 34143959 | |
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 4.78e-05 | 11 | 33 | 2 | 23968836 | |
| Pubmed | Conditional stabilization of beta-catenin expands the pool of lung stem cells. | 6.77e-05 | 13 | 33 | 2 | 18356571 | |
| Pubmed | 1.18e-04 | 100 | 33 | 3 | 10048485 | ||
| Pubmed | 1.27e-04 | 844 | 33 | 6 | 25963833 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.32e-04 | 18 | 33 | 2 | 18834073 | |
| Pubmed | 1.33e-04 | 104 | 33 | 3 | 9205841 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 1.64e-04 | 20 | 33 | 2 | 29961574 | |
| Pubmed | Crumbs 2 prevents cortical abnormalities in mouse dorsal telencephalon. | 1.64e-04 | 20 | 33 | 2 | 26802325 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.74e-04 | 560 | 33 | 5 | 21653829 | |
| Pubmed | 1.81e-04 | 21 | 33 | 2 | 19686682 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 1.81e-04 | 21 | 33 | 2 | 19601998 | |
| Pubmed | 1.93e-04 | 118 | 33 | 3 | 21078624 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.99e-04 | 22 | 33 | 2 | 26494785 | |
| Pubmed | 2.54e-04 | 608 | 33 | 5 | 16713569 | ||
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 2.58e-04 | 25 | 33 | 2 | 34391772 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 2.99e-04 | 630 | 33 | 5 | 36949045 | |
| Pubmed | 3.02e-04 | 27 | 33 | 2 | 23001562 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 3.49e-04 | 29 | 33 | 2 | 31491374 | |
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 3.49e-04 | 29 | 33 | 2 | 21402740 | |
| Pubmed | 3.74e-04 | 30 | 33 | 2 | 19054571 | ||
| Pubmed | The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. | 4.53e-04 | 33 | 33 | 2 | 23213461 | |
| Pubmed | MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons. | 5.09e-04 | 35 | 33 | 2 | 22407321 | |
| Pubmed | 5.39e-04 | 36 | 33 | 2 | 27736991 | ||
| Pubmed | 5.78e-04 | 407 | 33 | 4 | 12693553 | ||
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 6.01e-04 | 38 | 33 | 2 | 27930960 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 6.33e-04 | 39 | 33 | 2 | 19010793 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 8.33e-04 | 1201 | 33 | 6 | 35696571 | |
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 9.19e-04 | 47 | 33 | 2 | 32747435 | |
| Interaction | LCE3C interactions | 6.55e-08 | 67 | 32 | 5 | int:LCE3C | |
| Interaction | LCE1D interactions | 8.19e-08 | 70 | 32 | 5 | int:LCE1D | |
| Interaction | SMCP interactions | 1.51e-07 | 79 | 32 | 5 | int:SMCP | |
| Interaction | POU4F2 interactions | 1.94e-07 | 83 | 32 | 5 | int:POU4F2 | |
| Interaction | LCE2C interactions | 2.60e-07 | 88 | 32 | 5 | int:LCE2C | |
| Interaction | LCE1F interactions | 3.25e-07 | 92 | 32 | 5 | int:LCE1F | |
| Interaction | ATN1 interactions | 4.37e-07 | 187 | 32 | 6 | int:ATN1 | |
| Interaction | LCE3B interactions | 8.15e-07 | 46 | 32 | 4 | int:LCE3B | |
| Interaction | HOXA1 interactions | 1.16e-06 | 356 | 32 | 7 | int:HOXA1 | |
| Interaction | CFC1 interactions | 1.55e-06 | 126 | 32 | 5 | int:CFC1 | |
| Interaction | KRTAP5-2 interactions | 2.74e-06 | 62 | 32 | 4 | int:KRTAP5-2 | |
| Interaction | KRTAP5-4 interactions | 2.92e-06 | 63 | 32 | 4 | int:KRTAP5-4 | |
| Interaction | KRTAP10-11 interactions | 3.11e-06 | 64 | 32 | 4 | int:KRTAP10-11 | |
| Interaction | KRTAP5-11 interactions | 3.52e-06 | 66 | 32 | 4 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 3.52e-06 | 66 | 32 | 4 | int:KRTAP5-3 | |
| Interaction | NR1D2 interactions | 3.74e-06 | 67 | 32 | 4 | int:NR1D2 | |
| Interaction | LCE1E interactions | 3.97e-06 | 68 | 32 | 4 | int:LCE1E | |
| Interaction | NR4A3 interactions | 4.21e-06 | 69 | 32 | 4 | int:NR4A3 | |
| Interaction | LCE2A interactions | 4.21e-06 | 69 | 32 | 4 | int:LCE2A | |
| Interaction | FIBIN interactions | 4.72e-06 | 71 | 32 | 4 | int:FIBIN | |
| Interaction | SLC13A5 interactions | 4.74e-06 | 21 | 32 | 3 | int:SLC13A5 | |
| Interaction | VGLL3 interactions | 4.99e-06 | 72 | 32 | 4 | int:VGLL3 | |
| Interaction | VASN interactions | 5.02e-06 | 160 | 32 | 5 | int:VASN | |
| Interaction | LCE3D interactions | 5.28e-06 | 73 | 32 | 4 | int:LCE3D | |
| Interaction | GALNT14 interactions | 5.49e-06 | 22 | 32 | 3 | int:GALNT14 | |
| Interaction | LCE2D interactions | 5.57e-06 | 74 | 32 | 4 | int:LCE2D | |
| Interaction | CREB5 interactions | 5.66e-06 | 164 | 32 | 5 | int:CREB5 | |
| Interaction | KRTAP4-5 interactions | 6.20e-06 | 76 | 32 | 4 | int:KRTAP4-5 | |
| Interaction | LCE3A interactions | 6.20e-06 | 76 | 32 | 4 | int:LCE3A | |
| Interaction | LCE1C interactions | 6.53e-06 | 77 | 32 | 4 | int:LCE1C | |
| Interaction | LCE4A interactions | 7.61e-06 | 80 | 32 | 4 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 7.99e-06 | 81 | 32 | 4 | int:KRTAP4-4 | |
| Interaction | LCE2B interactions | 7.99e-06 | 81 | 32 | 4 | int:LCE2B | |
| Interaction | LCE1A interactions | 9.24e-06 | 84 | 32 | 4 | int:LCE1A | |
| Interaction | KRTAP3-1 interactions | 9.68e-06 | 85 | 32 | 4 | int:KRTAP3-1 | |
| Interaction | LCE1B interactions | 9.68e-06 | 85 | 32 | 4 | int:LCE1B | |
| Interaction | SDF2L1 interactions | 1.01e-05 | 322 | 32 | 6 | int:SDF2L1 | |
| Interaction | LCE5A interactions | 1.22e-05 | 90 | 32 | 4 | int:LCE5A | |
| Interaction | KRTAP4-11 interactions | 1.33e-05 | 92 | 32 | 4 | int:KRTAP4-11 | |
| Interaction | KRTAP5-6 interactions | 1.44e-05 | 94 | 32 | 4 | int:KRTAP5-6 | |
| Interaction | KRTAP2-3 interactions | 1.51e-05 | 95 | 32 | 4 | int:KRTAP2-3 | |
| Interaction | KRTAP4-1 interactions | 1.59e-05 | 31 | 32 | 3 | int:KRTAP4-1 | |
| Interaction | KRTAP5-9 interactions | 1.59e-05 | 203 | 32 | 5 | int:KRTAP5-9 | |
| Interaction | LILRA5 interactions | 1.75e-05 | 32 | 32 | 3 | int:LILRA5 | |
| Interaction | KRTAP9-8 interactions | 1.84e-05 | 100 | 32 | 4 | int:KRTAP9-8 | |
| Interaction | KRTAP2-4 interactions | 1.92e-05 | 101 | 32 | 4 | int:KRTAP2-4 | |
| Interaction | KRTAP1-1 interactions | 2.30e-05 | 219 | 32 | 5 | int:KRTAP1-1 | |
| Interaction | KRTAP11-1 interactions | 2.50e-05 | 108 | 32 | 4 | int:KRTAP11-1 | |
| Interaction | SPRY1 interactions | 2.78e-05 | 111 | 32 | 4 | int:SPRY1 | |
| Interaction | NBPF19 interactions | 3.09e-05 | 233 | 32 | 5 | int:NBPF19 | |
| Interaction | KRTAP10-9 interactions | 3.63e-05 | 241 | 32 | 5 | int:KRTAP10-9 | |
| Interaction | IGFBP4 interactions | 3.72e-05 | 41 | 32 | 3 | int:IGFBP4 | |
| Interaction | ALPP interactions | 4.16e-05 | 123 | 32 | 4 | int:ALPP | |
| Interaction | CACNA1A interactions | 4.16e-05 | 123 | 32 | 4 | int:CACNA1A | |
| Interaction | NUFIP2 interactions | 4.35e-05 | 417 | 32 | 6 | int:NUFIP2 | |
| Interaction | ITGB4 interactions | 4.43e-05 | 125 | 32 | 4 | int:ITGB4 | |
| Interaction | CATSPER1 interactions | 4.57e-05 | 126 | 32 | 4 | int:CATSPER1 | |
| Interaction | KRTAP13-1 interactions | 4.61e-05 | 44 | 32 | 3 | int:KRTAP13-1 | |
| Interaction | KRTAP12-2 interactions | 4.86e-05 | 128 | 32 | 4 | int:KRTAP12-2 | |
| Interaction | MPP4 interactions | 5.10e-05 | 7 | 32 | 2 | int:MPP4 | |
| Interaction | KRTAP4-2 interactions | 5.48e-05 | 132 | 32 | 4 | int:KRTAP4-2 | |
| Interaction | CNTNAP3B interactions | 6.77e-05 | 50 | 32 | 3 | int:CNTNAP3B | |
| Interaction | KRTAP9-3 interactions | 6.90e-05 | 140 | 32 | 4 | int:KRTAP9-3 | |
| Interaction | SLURP1 interactions | 7.69e-05 | 144 | 32 | 4 | int:SLURP1 | |
| Interaction | KRTAP9-2 interactions | 8.78e-05 | 149 | 32 | 4 | int:KRTAP9-2 | |
| Interaction | FBXO34 interactions | 9.02e-05 | 55 | 32 | 3 | int:FBXO34 | |
| Interaction | TRGV3 interactions | 9.02e-05 | 55 | 32 | 3 | int:TRGV3 | |
| Interaction | KRTAP10-7 interactions | 9.16e-05 | 293 | 32 | 5 | int:KRTAP10-7 | |
| Interaction | KRTAP10-1 interactions | 9.73e-05 | 153 | 32 | 4 | int:KRTAP10-1 | |
| Interaction | OTX1 interactions | 1.02e-04 | 155 | 32 | 4 | int:OTX1 | |
| Interaction | BTNL2 interactions | 1.02e-04 | 155 | 32 | 4 | int:BTNL2 | |
| Interaction | LYPD1 interactions | 1.06e-04 | 58 | 32 | 3 | int:LYPD1 | |
| Interaction | ADAM12 interactions | 1.06e-04 | 58 | 32 | 3 | int:ADAM12 | |
| Interaction | INSL5 interactions | 1.06e-04 | 58 | 32 | 3 | int:INSL5 | |
| Interaction | KRTAP10-5 interactions | 1.16e-04 | 160 | 32 | 4 | int:KRTAP10-5 | |
| Interaction | LCE3E interactions | 1.17e-04 | 60 | 32 | 3 | int:LCE3E | |
| Interaction | KRTAP4-12 interactions | 1.19e-04 | 161 | 32 | 4 | int:KRTAP4-12 | |
| Interaction | KRTAP12-1 interactions | 1.35e-04 | 63 | 32 | 3 | int:KRTAP12-1 | |
| Interaction | PHLDA1 interactions | 1.55e-04 | 66 | 32 | 3 | int:PHLDA1 | |
| Interaction | DOCK2 interactions | 1.55e-04 | 66 | 32 | 3 | int:DOCK2 | |
| Interaction | CRCT1 interactions | 1.55e-04 | 66 | 32 | 3 | int:CRCT1 | |
| Interaction | CRB1 interactions | 1.60e-04 | 12 | 32 | 2 | int:CRB1 | |
| Interaction | CRIPTO interactions | 1.77e-04 | 69 | 32 | 3 | int:CRIPTO | |
| Interaction | KRTAP1-3 interactions | 1.98e-04 | 184 | 32 | 4 | int:KRTAP1-3 | |
| Interaction | IGFL3 interactions | 2.27e-04 | 75 | 32 | 3 | int:IGFL3 | |
| Interaction | CST11 interactions | 2.27e-04 | 75 | 32 | 3 | int:CST11 | |
| Interaction | GLRX3 interactions | 2.28e-04 | 191 | 32 | 4 | int:GLRX3 | |
| Interaction | SRY interactions | 2.53e-04 | 15 | 32 | 2 | int:SRY | |
| Interaction | CST9L interactions | 2.55e-04 | 78 | 32 | 3 | int:CST9L | |
| Interaction | KRTAP3-2 interactions | 2.65e-04 | 79 | 32 | 3 | int:KRTAP3-2 | |
| Interaction | BMP7 interactions | 2.75e-04 | 80 | 32 | 3 | int:BMP7 | |
| Interaction | DNAJB9 interactions | 2.83e-04 | 202 | 32 | 4 | int:DNAJB9 | |
| Interaction | NOTCH2NLA interactions | 3.11e-04 | 381 | 32 | 5 | int:NOTCH2NLA | |
| Interaction | KRTAP13-3 interactions | 3.29e-04 | 85 | 32 | 3 | int:KRTAP13-3 | |
| Interaction | GUCD1 interactions | 3.64e-04 | 88 | 32 | 3 | int:GUCD1 | |
| Interaction | ADAMTSL4 interactions | 3.71e-04 | 217 | 32 | 4 | int:ADAMTSL4 | |
| Interaction | LY86 interactions | 3.71e-04 | 217 | 32 | 4 | int:LY86 | |
| Interaction | NAAA interactions | 3.91e-04 | 220 | 32 | 4 | int:NAAA | |
| Interaction | KRTAP10-8 interactions | 3.93e-04 | 401 | 32 | 5 | int:KRTAP10-8 | |
| Interaction | LMNTD2 interactions | 4.11e-04 | 19 | 32 | 2 | int:LMNTD2 | |
| Cytoband | 17q12-q21 | 7.84e-09 | 32 | 33 | 4 | 17q12-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.01e-06 | 473 | 33 | 6 | chr17q21 | |
| Cytoband | 17q21.2 | 1.17e-03 | 70 | 33 | 2 | 17q21.2 | |
| Cytoband | 1q21.3 | 3.23e-03 | 117 | 33 | 2 | 1q21.3 | |
| Cytoband | 11p15.5 | 3.28e-03 | 118 | 33 | 2 | 11p15.5 | |
| GeneFamily | Keratin associated proteins | 3.88e-09 | 109 | 23 | 6 | 619 | |
| GeneFamily | CD molecules|Mucins | 3.20e-04 | 21 | 23 | 2 | 648 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | JAG2 KRTAP9-9 HRNR KRTAP9-6 KRTAP9-1 KRTAP9-2 KRTAP9-8 LCE5A KRTAP9-3 | 2.88e-12 | 204 | 33 | 9 | MM966 |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.11e-05 | 630 | 33 | 7 | MM1038 | |
| Coexpression | NABA_MATRISOME | 2.74e-05 | 1008 | 33 | 8 | MM17056 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR | 2.76e-05 | 483 | 33 | 6 | MM1012 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.08e-05 | 738 | 33 | 7 | MM17058 | |
| Coexpression | NABA_MATRISOME | 3.11e-05 | 1026 | 33 | 8 | M5889 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 3.22e-05 | 49 | 33 | 3 | MM452 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.44e-05 | 751 | 33 | 7 | M5885 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.42e-04 | 650 | 33 | 6 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.53e-04 | 659 | 33 | 6 | MM1040 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.69e-07 | 219 | 25 | 6 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 1.15e-05 | 990 | 25 | 8 | JC_hmvEC_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 1.89e-05 | 495 | 25 | 6 | JC_hmvEC_500 | |
| CoexpressionAtlas | BM Top 100 - cerebellum | 6.87e-05 | 68 | 25 | 3 | BM Top 100 - cerebellum | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.56e-05 | 936 | 25 | 7 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000 | 1.02e-04 | 981 | 25 | 7 | PCBC_ctl_PulmonMicrovasc_1000 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.24e-04 | 428 | 25 | 5 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_100 | 2.10e-04 | 99 | 25 | 3 | PCBC_ctl_PulmonMicrovasc_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_500 | 2.44e-04 | 495 | 25 | 5 | PCBC_ctl_PulmonMicrovasc_500 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.30e-08 | 146 | 32 | 5 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-07 | 189 | 32 | 5 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-07 | 193 | 32 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.80e-07 | 197 | 32 | 5 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.41e-06 | 154 | 32 | 4 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-06 | 177 | 32 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.81e-06 | 178 | 32 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.99e-06 | 179 | 32 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.99e-06 | 179 | 32 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.99e-06 | 179 | 32 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.90e-06 | 184 | 32 | 4 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-06 | 188 | 32 | 4 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 9.89e-06 | 189 | 32 | 4 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 192 | 32 | 4 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 192 | 32 | 4 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 32 | 4 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 195 | 32 | 4 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 195 | 32 | 4 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 195 | 32 | 4 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 196 | 32 | 4 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.00e-05 | 106 | 32 | 3 | 117b53d525be929652fb998e250d7946170fbaf0 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.07e-04 | 129 | 32 | 3 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 135 | 32 | 3 | c7c30b993b3ddac8f1677d5fe47dc2e66d0d26ac | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-04 | 142 | 32 | 3 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-04 | 143 | 32 | 3 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-04 | 143 | 32 | 3 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 148 | 32 | 3 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-04 | 155 | 32 | 3 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 158 | 32 | 3 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 166 | 32 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-04 | 169 | 32 | 3 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 2.47e-04 | 171 | 32 | 3 | 098a7fd387357c0d4e1a6169af4d24ef95b30018 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 172 | 32 | 3 | bd73fd3520064d430a153cfdd5c2858b6c184c59 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.51e-04 | 172 | 32 | 3 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 2.51e-04 | 172 | 32 | 3 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.51e-04 | 172 | 32 | 3 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-04 | 172 | 32 | 3 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 172 | 32 | 3 | 47ee78ed3ba6516dad8f12dbf70bca5ed1c60aff | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-04 | 172 | 32 | 3 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.55e-04 | 173 | 32 | 3 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-04 | 174 | 32 | 3 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 174 | 32 | 3 | 583955b4db442ba0583e2312af242f050547f9d6 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 174 | 32 | 3 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 2.60e-04 | 174 | 32 | 3 | 05d54a36772f096047521e16a89cc42ae48d2a1d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 175 | 32 | 3 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 176 | 32 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-04 | 177 | 32 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-04 | 177 | 32 | 3 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.82e-04 | 179 | 32 | 3 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.82e-04 | 179 | 32 | 3 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 179 | 32 | 3 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-04 | 180 | 32 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 182 | 32 | 3 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.96e-04 | 182 | 32 | 3 | f2a1784ffcba9b27132e0db21e574cbd8a0a6418 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.96e-04 | 182 | 32 | 3 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 183 | 32 | 3 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.06e-04 | 184 | 32 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-04 | 185 | 32 | 3 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 185 | 32 | 3 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.11e-04 | 185 | 32 | 3 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 185 | 32 | 3 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-04 | 186 | 32 | 3 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 186 | 32 | 3 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 186 | 32 | 3 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 186 | 32 | 3 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 186 | 32 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 187 | 32 | 3 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 187 | 32 | 3 | 106f50ad85a92403037214f0e94702230284837f | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 187 | 32 | 3 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 81754e965848b718be20ee97ce072ce426938a69 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-04 | 187 | 32 | 3 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 188 | 32 | 3 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-04 | 188 | 32 | 3 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.26e-04 | 188 | 32 | 3 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 188 | 32 | 3 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.81e-08 | 8 | 27 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | cystitis (is_marker_for) | 8.06e-07 | 2 | 27 | 2 | DOID:1679 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 2.42e-06 | 3 | 27 | 2 | OBA_2050332 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 8.05e-06 | 5 | 27 | 2 | DOID:3030 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 2.89e-05 | 9 | 27 | 2 | EFO_0009824 | |
| Disease | age at onset, multiple sclerosis | 3.61e-05 | 10 | 27 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | Autistic Disorder | 8.94e-05 | 261 | 27 | 4 | C0004352 | |
| Disease | cardiac arrhythmia | 3.45e-04 | 30 | 27 | 2 | EFO_0004269 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.58e-04 | 152 | 27 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 5.26e-04 | 37 | 27 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 6.79e-04 | 42 | 27 | 2 | DOID:12849 (is_implicated_in) | |
| Disease | pneumonia | 8.50e-04 | 47 | 27 | 2 | EFO_0003106 | |
| Disease | eye colour measurement | 1.02e-03 | 218 | 27 | 3 | EFO_0009764 | |
| Disease | cystic fibrosis (is_marker_for) | 1.47e-03 | 62 | 27 | 2 | DOID:1485 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.57e-03 | 64 | 27 | 2 | DOID:4947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACYGSGICSCSGDVT | 461 | Q5FYA8 | |
| CDCLGTGYTGETCHS | 571 | Q9BZ76 | |
| CAQGCTNTDGSFHCS | 396 | Q9NPY3 | |
| SSSKYCCDTGNHGSE | 126 | Q8N6M6 | |
| NGADCHSITGGCTCA | 411 | A6BM72 | |
| SCAAGGSYACAGSCK | 6 | P0DM35 | |
| SCICDSGFTGTYCHE | 621 | Q9Y219 | |
| CCNLEYHSSGTLCGS | 566 | O75335 | |
| TCEGNATNCHSCEGG | 1286 | Q92824 | |
| CTQAVCHGTCSIYGS | 851 | Q02817 | |
| SGTSCSSSCGHYESG | 796 | Q86YZ3 | |
| LQECSAYCGSHGTCA | 171 | Q7Z7M0 | |
| HASVCCTGSCYSAVG | 396 | Q96JB8 | |
| GATYSTDCTNCTCSG | 406 | P98088 | |
| EASGCHYGALTCGSC | 566 | P10275 | |
| SGHGYCTTGAICICD | 3236 | P78509 | |
| CHYDGGDCCSSTLSS | 1751 | Q9BXP8 | |
| GGSSCCSQTCNESSY | 196 | A8MXZ3 | |
| CGSSCGQSSSCAPVY | 101 | Q9BYQ4 | |
| CGSSCGQSSSCAPVY | 86 | Q9BYQ3 | |
| CCHSSGGSGCCHSSG | 101 | Q5TCM9 | |
| CGSSCGQSSSCAPVY | 101 | A8MVA2 | |
| CGSSCGQSSSCAPVY | 86 | Q9BYQ0 | |
| CGSSCGQSSSCAPVY | 81 | Q9BYP9 | |
| TSGFISGCSGHCTSY | 956 | Q9UHC6 | |
| SGCSGHCTSYGTNCE | 961 | Q9UHC6 | |
| HCTSYGTNCENGGKC | 966 | Q9UHC6 | |
| CNCTGSGFTGTHCET | 286 | P82279 | |
| GATCISHTNGYSCLC | 1226 | P82279 | |
| CDCLGTGYTGETCHS | 571 | Q96NU0 | |
| GCSGSGDQHCRCSST | 241 | Q8N2Y8 | |
| VCGDCTGYGASCVSS | 771 | O75592 | |
| CYSCKGNSTHGCSSE | 216 | Q03405 | |
| SSCSQCGKTYCQSGS | 1531 | O15015 | |
| YSCGECGKGFSCSSH | 461 | Q9UJW7 | |
| VGACTAHTYSCGSGV | 1656 | Q8IWV8 |